Valeant Pharmaceuticals Intl (VRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRX | MDGL | GRFS | ||
| Company | Valeant Pharmaceuticals Intl | Madrigal Pharmaceuticals Inc | Grifols S.A. ADR | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 24.15 | 427.28 | 7.90 | ||
| High | 24.43 | 441.37 | 8.03 | ||
| Low | 23.36 | 421.55 | 7.85 | ||
| Latest | 23.40 | 438.13 | 7.99 | ||
| Change | -0.83 | +6.60 | -0.04 | ||
| % Change | -3.43% | +1.53% | -0.50% | ||
| Volume | 6,569,300 | 162,184 | 993,190 | ||
| 20-Day Average Volume | 6,685,200 | 374,583 | 759,428 | ||
| Previous Close | 24.23 | 431.53 | 8.03 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 23.73 | 444.30 | 8.94 | ||
| 20-Day Raw Stochastic | 18.46% | 29.34% | 7.55% | ||
| 20-Day Relative Strength | 52.09 | 41.82 | 34.40 | ||
| Weighted Alpha | +35.20 | +22.70 | -7.82 | ||
| Today's Opinion | N/A | 24% Sell | 88% Sell | ||
| Previous Opinion | N/A | 24% Sell | 88% Sell | ||
| Last Month's Opinion | N/A | 8% Buy | 16% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.92% since 07/06/18 | +0.20% since 03/05/26 | -6.93% since 03/05/26 | ||
| Low | 23.02 on 07/09/18 | 418.72 on 03/09/26 | 7.85 on 03/12/26 | ||
| High | 24.43 on 07/13/18 | 443.42 on 03/10/26 | 8.77 on 03/09/26 | ||
| 1-Month | |||||
| %Chg | -12.88% since 06/13/18 | -7.08% since 02/12/26 | -13.85% since 02/12/26 | ||
| Low | 22.56 on 06/28/18 | 416.21 on 03/03/26 | 7.85 on 03/12/26 | ||
| High | 27.25 on 06/14/18 | 498.10 on 02/18/26 | 9.77 on 02/18/26 | ||
| 3-Month | |||||
| %Chg | +36.44% since 04/13/18 | -22.96% since 12/12/25 | -12.53% since 12/12/25 | ||
| Low | 16.76 on 04/16/18 | 416.21 on 03/03/26 | 7.85 on 03/12/26 | ||
| High | 27.79 on 06/13/18 | 615.00 on 12/24/25 | 9.77 on 02/18/26 | ||
| 6-Month | |||||
| %Chg | -1.85% since 01/12/18 | +1.85% since 09/12/25 | -19.08% since 09/12/25 | ||
| Low | 14.44 on 03/02/18 | 393.61 on 10/29/25 | 7.64 on 12/02/25 | ||
| High | 27.79 on 06/13/18 | 615.00 on 12/24/25 | 10.23 on 10/02/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,159,814 | 9,899,298 | 5,521,107 | ||
| Shares Outstanding, K | 348,710 | 22,940 | 687,560 | ||
| Annual Sales | 8,724,000,000 | 958,400,000 | 8,512,650,000 | ||
| Annual Net Income | 2,404,000,000 | -288,280,000 | 565,700,000 | ||
| Last Quarter Sales | 1,995,000,000 | 321,080,000 | 2,304,030,000 | ||
| Last Quarter Net Income | -2,693,000,000 | -58,570,000 | 221,480,000 | ||
| 60-Month Beta | -0.38 | -0.97 | 0.67 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.89 on 05/08/18 | -2.57 on 02/19/26 | 0.19 on 07/28/25 | ||
| Latest Earnings Date | 08/14/18 | 05/07/26 | 02/25/26 | ||
| Most Recent Dividend | 1.000 on 11/10/10 | N/A | 0.142 on 08/12/25 | ||
| Next Ex-Dividends Date | N/A | N/A | 08/12/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 6.12 | 0.00 | 0.00 | ||